Breast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read MoreBreast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read MoreProtean BioDiagnostics has been featured in “Careers in The Corridor,” a spotlight on opportunities for high-skill, high-value careers across the 23-county Florida High Tech Corridor region.
Read MoreProtean BioDiagnostics, an Orlando based innovative diagnostics company is focusing its innovative test development efforts on helping patients with breast cancer using innovative new approaches for cancer diagnostics.
Read MoreBreast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read MoreA liquid biopsy is essentially a simple blood test. But that’s not all. With today’s advanced technology we can now examine the blood of cancer patients with unprecedented accuracy and sensitivity to detect important features of the disease that can be extremely helpful to better plan treatment.
Read More
